Want to see IN:MKPL full AI Analyst Report?

M K Proteins Limited (MKPL) Price & Analysis

0 Followers

MKPL Stock Chart & Stats

₹6.89

-₹0.11(-1.36%)

At close: Jan 08 4:00 PM EST

₹6.89

-₹0.11(-1.36%)

Day’s Range― - ―

52-Week Range₹3.80 - ₹8.84

Previous CloseN/A

Volume181.52K

Average Volume (3M)17.89K

Market Cap

₹1.51B

Enterprise Value₹1.82K

Total Cash (Recent Filing)₹4.38M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)31.7

Beta0.96

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.12

Shares Outstanding375,372,000

10 Day Avg. Volume20,598

30 Day Avg. Volume17,885

Financial Highlights & Ratios

PEG Ratio-1.18

Price to Book (P/B)1.92

Price to Sales (P/S)0.38

P/FCF Ratio76.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue ReboundThe strong FY2026 sales rebound shows the business can regain demand after weaker years. Sustained revenue growth would improve operating leverage and provide a larger base from which to rebuild profitability.

Improved LeverageLower leverage reduces balance-sheet pressure and improves financial flexibility. Rising equity also provides a stronger capital buffer, helping the company absorb operating volatility while funding ongoing business needs.

Positive FY2026 Cash FlowAlthough cash conversion remains weak, positive operating and free cash flow in FY2026 indicate the business can generate cash in a stronger revenue year. Maintaining this profile would support reinvestment and debt servicing.

Bears Say

Severe Margin CompressionThe sharp decline in gross and net margins signals weaker pricing power, higher costs, or an unfavorable mix. Unless margins stabilize, additional revenue may translate into limited earnings and weaker resilience.

Inconsistent Cash ConversionRepeated negative operating cash flow points to working-capital volatility or poor earnings conversion. This limits internally funded growth, increases reliance on financing, and raises execution risk during another operating downturn.

Declining EarningsEarnings are weakening despite the revenue rebound, indicating that cost and margin pressures are offsetting sales growth. Continued profit declines could restrict reinvestment, weaken balance-sheet coverage, and undermine operating sustainability.

M K Proteins Limited News

M K Proteins Closes Trading Window Ahead of Q1 FY2026 Results

M K Proteins Limited ( ($IN:MKPL) ) has issued an announcement. M K Proteins Limited has announced the...

3M ago

MKPL

MKPL FAQ

What was M K Proteins Limited’s price range in the past 12 months?

M K Proteins Limited lowest stock price was ₹3.80 and its highest was ₹8.84 in the past 12 months.

What is M K Proteins Limited’s market cap?

M K Proteins Limited’s market cap is ₹1.51B.

When is M K Proteins Limited’s upcoming earnings report date?

M K Proteins Limited’s upcoming earnings report date is Nov 12, 2026 which is in 59 days.

How were M K Proteins Limited’s earnings last quarter?

M K Proteins Limited released its earnings results on Aug 13, 2026. The company reported ₹0.037 earnings per share for the quarter.

Is M K Proteins Limited overvalued?

According to Wall Street analysts M K Proteins Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does M K Proteins Limited pay dividends?

M K Proteins Limited does not currently pay dividends.

What is M K Proteins Limited’s EPS estimate?

M K Proteins Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does M K Proteins Limited have?

M K Proteins Limited has 375,372,000 shares outstanding.

What happened to M K Proteins Limited’s price movement after its last earnings report?

M K Proteins Limited reported an EPS of ₹0.037 in its last earnings report. Following the earnings report the stock price went up 0.957%.

Which hedge fund is a major shareholder of M K Proteins Limited?

Currently, no hedge funds are holding shares in IN:MKPL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M K Proteins Limited

M. K. Proteins Limited specializes in the production and commercial activities related to a range of refined vegetable oils and their associated derivatives. The company's diverse offerings include refined varieties such as rice bran, sunflower, cottonseed, soybean, palm, canola, and bleached rice bran oils. Furthermore, it provides by-products like rice bran fatty acid oils, rice bran waxes, gums, and spent earth. The firm also participates in the import and trade of both edible and non-edible oils. Founded in 2012, the company's operations are headquartered in Ambala, India.